Metamizole Noridem

Metamizole Sodium Monohydrate, the active ingredient in Metamizole Noridem, is a pyrazolone analgesic presented as a sterile powder for reconstitution for intramuscular or intravenous use. It is employed to relieve moderate to severe pain and to reduce fever in adult patients.

GNH USA supplies Metamizole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Metamizole is a pyrazolone analgesic used primarily for pain and fever management.

Acute pain: provides analgesia for moderate to severe pain. Post‑operative pain: reduces discomfort following surgical procedures. Fever: lowers elevated body temperature in febrile patients.

Metamizole may cause a range of adverse reactions.

Common Side Effects: - Injection site pain: local discomfort at the site of administration. - Nausea: mild to moderate upset stomach. - Dizziness: transient light‑headedness. - Transient leukopenia: temporary reduction in white blood cells.

Serious or Rare Side Effects: - Agranulocytosis: severe depletion of neutrophils, potentially life‑threatening. - Severe allergic reactions: including anaphylaxis and angioedema. - Stevens‑Johnson syndrome: rare but serious skin and mucous membrane disorder.

Use Metamizole with caution in specific clinical situations.

Renal impairment: monitor kidney function and adjust use as needed. Hepatic disease: avoid or use only under close supervision. History of blood disorders: contraindicated due to risk of agranulocytosis. Concurrent myelosuppressive therapy: monitor complete blood counts regularly. Pregnancy and lactation: safety not established; avoid unless clearly indicated. Store at ambient temperature: keep in original container, protect from moisture and light.

Metamizole can interact with several drug classes.

Major Interactions (Avoid): - Cytotoxic chemotherapy agents: increased risk of severe neutropenia. - Anticoagulants: potential enhancement of bleeding tendency. - Other pyrazolone derivatives: additive toxicity and blood dyscrasias.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible additive hypotensive effect. - Diuretics: monitor electrolytes and renal function. - NSAIDs: increased risk of renal impairment and gastrointestinal irritation.